ArticleFrontiers in endocrinology2025
Association between obesity indexes and chronic kidney disease risk: a double-cohort prospective study in the Binhai and UK Biobank.
Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Late-adolescent weight categories and early kidney disease in young adulthood: a nationwide study of Arab and Jewish Israelis.Pediatric nephrology (Berlin, Germany) · 2026Article
- Early mortality in multiple myeloma patients with renal impairment: a nested case-control study.BMC nephrology · 2026Article
- Article
- Association of obesity and lipid indexes with rapid kidney function decline and the progression to chronic kidney disease: a study from a large longitudinal cohort among middle-aged and older adults in China.Frontiers in medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: The prevalence of overweight and obesity has increased worldwide, leading to growing concern regarding the impact of visceral adipose deposition on renal function. The aim of this study was to evaluate the predictive value of 10 obesity indexes for the risk of chronic kidney disease (CKD) in both Chinese populations and Western. Methods: The Tianjin Chronic Kidney Disease Study (Binhai, primary cohort) included 126,109 participants, while 358,918 adults from the U.K. Biobank (UKB, replication cohort) were included. Cox proportional hazard and restricted cubic spline models were used to assess the relationships between obesity indexes and the risk of CKD. Results: During a median follow-up of 35 months in the Binhai cohort, 14,435 CKD cases were identified, while 358,918 CKD cases were observed in the U.K. Biobank cohort during 161 months of follow-up. The risk of CKD increased with increasing quartile levels of the Chinese Visceral Adiposity Index (CVAI) (P for trend < 0.001). CVAI was associated with increased CKD risk (hazard ratio in comparing the highest to the lowest quintile = 1.22 [95% CI 1.16-1.30]) and its predictive ability was the highest among the 10 obesity indexes, with an AUC value of 0.588 (0.581-0.594) in the female subgroup of the Binhai cohort. All of the obesity indexes were negatively correlated with estimated glomerular filtration rate (eGFR). Discussion: Findings from two large prospective cohort studies support the notion that obesity indexes, particularly CVAI, are significantly associated with the risk of CKD across diverse ethnic groups.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.